IRMD Iradimed Corp

$92.15 +1.17%

Healthcare · Surgical & Medical Instruments & Apparatus

Iradimed Corp (IRMD) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $1.2 billion. Shares last traded at $92.15, 14.3% below their 52-week high. Over the past year the stock is up 58.9%. IRMD trades at a price-to-earnings ratio of 52.40, above the Surgical & Medical Instruments & Apparatus median of 28.73. Net profit margin is 26.8%, above the peer median of -7.6%. Revenue grew 14.4% year over year.

Market Cap

$1.2B

Shares Out

12.8M

EPS (TTM)

$2.89

P/E Ratio

31.89

P/S Ratio

14.05

P/B Ratio

11.96

Dividend / Share

—

Dividend Yield

—

52-Week High

$107.50

52-Week Low

$55.72

Volume

5,772

Avg Vol (3m)

5,160.667

Performance

-4.31%

+5.41%

-7.59%

-4.88%

YTD

-3.43%

+58.93%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

50.82

SMA (50)

$90.21

SMA (200)

$90.01

Price vs SMA50

+2.15%

Price vs SMA200

+2.38%

ATR (14)

$3.26

Financials

Revenue

$84M

Net Income

$22M

Gross Margin

76.7%

Operating Margin

31.2%

Net Margin

26.8%

Return on Equity

22.8%

Return on Assets

19.7%

Current Ratio

7.13

Debt / Equity

0.16

Revenue Growth (YoY)

+14.4%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$0.45	2026-05-01
FY 2025	$1.75	2026-03-06
Q3 2025	$1.25	2025-11-03
Q2 2025	$0.82	2025-08-01
Q1 2026	$0.37	2026-05-01
FY 2025	$1.50	2026-03-06

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

IRMD vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/E vs peers

52.40 / 28.73 med

+82% premium

P/S vs peers

14.05 / 2.52 med

+458% premium

Net margin vs peers

26.8% / -7.6% med

above median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.